Menu Close

Trending

An inside peek into pharma marketing at PM Society learning event – part i
SABCS: AZ’s oral SERD data may “relaunch enthusiasm” for class
SABCS: New ADC from AZ and Daiichi shows promise in breast cancer
PharmStars digital health accelerator names its second class of 2022
Autolus announces primary endpoint met in FELIX trial, prices public offering

About ClaireMorris

Posts by ClaireMorris :

Articles/ Views and analysis

A new paradigm for drug discovery: part three – online shopping for scientists: new tools for finding and engaging service vendors

0 Comment

In part three of four, Dr Kevin Lustig and Dr Maria Thompson discuss how new tools for engaging service vendors can accelerate your drug discovery program. It will come as no surprise to anyone reading this that the pharmaceutical industry is currently suffering from quite a few problems…
X
A new paradigm for drug discovery: part three – online shopping for scientists: new tools for finding and engaging service vendors
https://pharmaphorum.com/views-and-analysis/a-new-paradigm-for-drug-discovery-part-three-online-shopping-for-scientists-new-tools-for-finding-and-engaging-service-vendors/

News

Bayer to spend $1.1 billion for contraceptive device

0 Comment

German pharma giant to make a large acquisition payment for device maker. Bayer will gain access to the contraceptive device Essure by acquiring its maker Conceptus for a purchase price of around $1.1 billion.
X
Bayer to spend $1.1 billion for contraceptive device
https://pharmaphorum.com/news/bayer_to_spend_1-1_billion_for_contraceptive_device_/

News

European Medicines Agency told not to disclose data

0 Comment

General Court of the European Union stops access to documents submitted to the European regulator. Following cases brought by AbbVie and InterMune, the European Medicines Agency has been told not to publish what the companies say is commercially sensitive data.
X
European Medicines Agency told not to disclose data
https://pharmaphorum.com/news/european_medicines_agency_told_not_to_disclose_data_/

Articles/ Views and analysis

Physician online communities – sponsor or build? (part 2)

0 Comment

Kay Wesley concludes her thoughts on whether pharma should sponsor or build physician online communities by exploring the pros and cons of both. In part one of this article, I considered the growth of online physician communities and the different types of community available –third party…
X
Physician online communities – sponsor or build? (part 2)
https://pharmaphorum.com/views-and-analysis/physician_online_communities_-_sponsor_or_build_part_2/

Articles/ Views and analysis

Market Access for nebulisers in asthma – UK payer insights

0 Comment

As our market access themed month commences, Dr Joanna Entwistle and Julia Glover explore market access barriers to nebulisers for asthma in the UK. Asthma is an inflammatory disease of the airways characterised by chronic inflammation associated with airway hyper-responsiveness…
X
Market Access for nebulisers in asthma – UK payer insights
https://pharmaphorum.com/views-and-analysis/market-access-for-nebulisers-in-asthma-uk-payer-insights/

Articles/ Views and analysis

Editor’s voice: April – digital and social media

0 Comment

Did you miss any of our digital and social media articles this month? An overview of highlights of this content is shared here. The discipline focus of our content throughout April has been on digital and social media. This article highlights some of my personal…
X
Editor’s voice: April – digital and social media
https://pharmaphorum.com/views-and-analysis/editors_voice_april_-_digital_and_social_media/

News

US eases emergency contraception restrictions

0 Comment

US regulator eases the availability of emergency contraception and relaxes its age restriction. Teva’s Plan B One-Step (levonorgestrel) ‘morning after’ pill is to become available over-the-counter in the US, removing the need to see a pharmacist, and it will be open to any woman or girl 15 years of age or older.
X
US eases emergency contraception restrictions
https://pharmaphorum.com/news/us_eases_emergency_contraception_restrictions/
1 2 3 4 ›»

Login

CONTINUE TO SITE >
X
Close in 10 seconds